Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

NCT00039858 is registered in ClinicalTrials.gov with Encysive Pharmaceuticals as lead sponsor.

NCT NCT00039858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00039858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
Lead sponsor
Encysive Pharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2003
Completion date
March 31, 2006
Enrollment
24
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopenia, thrombosis